Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 709-710, Issue , 2011, Pages 67-72

  García Quispes, Wilser Andrés ^a   Pérez Machado, Giselle ^a,e   Akdi, Abdelmounaim ^a   Pastor, Susana ^a,b   Galofré, Pere ^c,d   Biarnés, Fina ^d   Castell, Joan ^c   Velázquez, Antonia ^a,b   Marcos, Ricard ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

^e CENTRAL UNIVERSITY OF LAS VILLAS   (Cuba)

Author keywords

Genetic polymorphisms; OGG1; Thyroid cancer; XRCC1; XRCC2; XRCC3

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DNA REPAIR; ETHNICITY; EXCISION REPAIR; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HOMOLOGOUS RECOMBINATION; HOMOZYGOSITY; HUMAN; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; OGG1 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION; XRCC1 GENE; XRCC2 GENE; XRCC3 GENE;

ADULT; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; THYROID NEOPLASMS;

EID: 79954569244     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.03.003     Document Type: Article

References (52)

1. Akslen L.A., Haldorsen T., Thoresen S.O., Glattre E. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Cancer Res. 1991, 51:1234-1241.
2. Aschebrook-Kilfoy B., Ward M.H., Sabra M.M., Devesa S.S. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 2011, 21:125-134.
3. Gilfillan C.P. Review of the genetics of thyroid tumours: diagnostic and prognostic implications. ANZ J. Surg. 2010, 80:33-40.
4. Preston-Martin S., Franceschi S., Ron E., Negri E. Thyroid cancer pooled analysis from 14 case-control studies: what have we learned?. Cancer Causes Control 2003, 14:787-789.
5. Papadopoulou F., Efthimiou E. Thyroid cancer after external or internal ionizing irradiation. Hel. J. Nucl. Med. 2009, 12:266-270.
6. Hemminki K., Li X. Familiar risk of cancer by site and histopathology. Int. J. Cancer 2003, 103:105-109.
7. Hung R.J., Hall J., Brennan P., Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 2005, 162:925-942.
8. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
9. Berwick M., Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst. 2000, 92:874-897.
10. Manuguerra M., Saletta F., Karagas M.R., Berwick M., Veglia F., Vineis P., Matullo G. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am. J. Epidemiol. 2006, 164:297-302.
11. Naccarati A., Pardini B., Hemminki K., Vodicka P. Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat. Res. 2007, 635:118-145.
12. Hiroshi I., Mitsuharu K. Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol. Pharm. Bull. 2004, 27:480-485.
13. Le Marchand L., Donlon T., Lum-Jones A., Seifried A., Wilkens L.R. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomark. Prev. 2002, 11:409-412.
14. Xu J., Zheng S.L., Turner A., Isaacs S.D., Wiley K.E., Hawkins G.A., Chang B.L., Bleecker E.R., Walsh P.C., Meyers D.A., et al. Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res. 2002, 62:2253-2257.
15. Okasaka T., Matsuo K., Suzuki T., Ito H., Hosono S., Kawase T., Watanabe M., Yatabe Y., Hida T., Mitsudomi T., et al. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. J. Hum. Genet. 2009, 54:739-745.
16. Marsin S., Vidal A.E., Sossou M., Ménissier-de Murcia J., Le Page F., Boiteux S., de Murcia G., Radicella J.P. Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J. Biol. Chem. 2003, 278:44068-44074.
17. Schneider J., Classen V., Helmig S. XRCC1 polymorphism and lung cancer risk. Exp. Rev. Mol. Diag. 2008, 8:761-780.
18. Zipprich J., Terry M.B., Brandt-Rauf P., Freyer G.A., Liao Y., Agrawal M., Gurvich I., Senie R., Santella R.M. XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: a family-based case-control study. J. Carcinog. 2010, 16(9):4.
19. Yang Y., Zhai X.D., Gao L.B., Li S.L., Wang Z., Chen G.D. Genetic polymorphisms of DNA repair gene XRCC1 and risk of uterine leiomyoma. Mol. Cell. Biochem. 2010, 338:143-147.
20. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomark. Prev. 2002, 11:1513-1530.
21. Chiang F.Y., Wu C.W., Hsiao P.J., Kuo W.R., Lee K.W., Lin J.C., Liao Y.C., Juo S.H. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin. Cancer Res. 2008, 14:5919-5924.
22. Akulevich N.M., Saenko V.A., Rogounovitch T.I., Drozd V.M., Lushnikov E.F., Ivanov V.K., Mitsutake N., Kominami R., Yamashita S. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocrinol. Rel. Cancer 2009, 16:491-503.
23. Ho T., Li G., Lu J., Zhao C., Wei Q., Sturgis E.M. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid 2009, 19:129-135.
24. Johnson R.D., Liu N., Jasin M. Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination. Nature 1999, 401:397-399.
25. Brenneman M.A., Weiss A.E., Nickoloff J.A., Chen D.J. XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. Mutat. Res. 2000, 459:89-97.
26. Bastos H.N., Antão M.R., Silva S.N., Azevedo A.P., Manita I., Teixeira V., Pina J.E., Gil O.M., Ferreira T.C., Limbert E., et al. Association of polymorphisms in genes of the homologous recombination DNA repair pathway and thyroid cancer risk. Thyroid 2009, 19:1067-1075.
27. Sturgis E.M., Zhao C., Zheng R., Wei Q. Radiation response genotype and risk of differentiated thyroid cancer: a case control analysis. Laryngoscope 2005, 115:938-945.
28. Michiels S., Laplanche A., Boulet T., Dessen P., Guillonneau B., Méjean A., Desgrandchamps F., Lathrop M., Sarasin A., Benhamou S. Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk. Carcinogenesis 2009, 30:763-768.
29. Solé X., Guinó E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
30. Trzeciak A.R., Nyaga S.G., Jaruga P., Lohani A., Dizdaroglu M., Evans M.K. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis 2004, 25:1359-1370.
31. Srivastava A., Srivastava K., Pandey S.N., Choudhuri G., Mittal B. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population. Ann. Surg. Oncol. 2009, 16:1695-1703.
32. Yuan W., Xu L., Feng Y., Yang Y., Chen W., Wang J., Pang D., Li D. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 2010, 122:835-842.
33. Aka P., Mateuca R., Buchet J.P., Thierens H., Kirsch-Volders M. Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations?. Mutat. Res. 2004, 556:169-181.
34. Bravard A., Vacher M., Moritz E., Vaslin L., Hall J., Epe B., Radicella J.P. Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res. 2009, 69:3642-3649.
35. Hu Z., Ma H., Chen F., Wei Q., Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomark. Prev. 2005, 14:1810-1818.
36. Tuimala J., Szekely G., Gundy S., Hirvonen A., Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 2002, 23:1003-1008.
37. Mateuca R., Aka P.V., De Boeck M., Hauspie R., Kirsch-Volders M., Lison D. Influence of hOGG1, XRCC1 and XRCC3 genotypes on biomarkers of genotoxicity in workers exposed to cobalt or hard metal dusts. Toxicol. Lett. 2005, 156:277-288.
38. Loizidou M.A., Michael T., Neuhausen S.L., Newbold R.F., Marcou Y., Kakouri E., Daniel M., Papadopoulos P., Malas S., Kyriacou K., et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res. Treat. 2008, 112:575-579.
39. Han J., Hankinson S.E., Ranu H., De Vivo I., Hunter D.J. Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study. Carcinogenesis 2004, 25:189-195.
40. Zhang Z., Wan J., Jin X., Jin T., Shen H., Lu D., Xia Z. Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population. Cancer Epidemiol. Biomark. Prev. 2005, 14:2614-2619.
41. Miao X., Zhang X., Zhang L., Guo Y., Hao B., Tan W., He F., Lin D. Adenosine diphosphate ribosyl transferase and X-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer. Gastroenterology 2006, 131:420-427.
42. Rafii S., O'Regan P., Xinarianos G., Azmy I., Stephenson T., Red M., Meuth M., Thacker J., Cox A. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum. Mol. Genet. 2002, 11:1433-1438.
43. Danoy P., Sonoda E., Lathrop M., Takeda S., Matsuda F. A naturally occurring genetic variant of human XRCC2 (R188H) confers increased resistance to cisplatin-induced DNA damage. Biochem. Biophys. Res. Commun. 2007, 352:763-768.
44. Curtin K., Lin W.Y., George R., Katory M., Shorto J., Cannon-Albright L.A., Smith G., Bishop D.T., Cox A., Camp N.J. Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol. Biomark. Prev. 2009, 18:2476-2484.
45. Yu K.D., Chen A.X., Qiu L.X., Fan L., Yang C., Shao Z.M. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37369 subjects. Breast Cancer Res. Treat. 2010, 123:219-225.
46. van Gils C.H., Bostick R.M., Stern M.C., Taylor J.A. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol. Biomark. Prev. 2002, 11:1279-1284.
47. Wang G.S., Cooper T.A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 2007, 8:749-761.
48. De Ruyck K., Van Eijkeren M., Claes K., Morthier R., De Paepe A., Vral A., De Ridder L., Thierens H. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62:1140-1149.
49. Kuschel B., Auranen A., McBride S., Novik K.L., Antoniou A., Lipscombe J.M., Day N.E., Easton D.F., Ponder B.A., Pharoah P.D., et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet. 2002, 11:1399-1407.
50. García-Closas M., Egan K.M., Newcomb P.A., Brinton L.A., Titus-Ernstoff L., Chanock S., Welch R., Lissowska J., Peplonska B., Szeszenia-Dabrowska N., et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum. Genet. 2006, 119:376-388.
51. Jiao L., Hassan M.M., Bondy M.L., Wolff R.A., Evans D.B., Abbruzzese J.L., Li D. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am. J. Gastroenterol. 2008, 103:360-367.
52. Adjadj E., Schlumberger M., de Vathaire F. Germ-line DNA polymorphisms and their susceptibility to differentiated thyroid cancer. Lancet Oncol. 2009, 10:181-190.